| 2026-01903 |
Notice |
FDA Rare Disease Innovation Hub Future Programming; Request ... |
Jan 30, 2026 |
| 2026-01587 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01575 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01577 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01585 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01576 |
Notice |
Agency Information Collection Activities; Proposed Collectio... |
Jan 27, 2026 |
| 2026-01574 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01588 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01573 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 27, 2026 |
| 2026-01288 |
Notice |
Cuffless Non-Invasive Blood Pressure Measuring Devices-Clini... |
Jan 23, 2026 |
| 2026-01296 |
Notice |
Tyler Jordan Hall: Final Debarment Order |
Jan 23, 2026 |
| 2026-01159 |
Notice |
FDA Records Access Authority for Cosmetics; Draft Guidance f... |
Jan 22, 2026 |
| 2026-01121 |
Notice |
Labeling and Preventing Cross-Contact of Gluten for Packaged... |
Jan 22, 2026 |
| 2026-01069 |
Notice |
Authorization of Emergency Use of Certain Medical Devices Du... |
Jan 21, 2026 |
| 2026-01073 |
Notice |
M4Q(R2) The Common Technical Document for the Registration o... |
Jan 21, 2026 |
| 2026-01084 |
Notice |
Notice of Approval of Product Under Voucher: Rare Pediatric ... |
Jan 21, 2026 |
| 2026-01068 |
Notice |
Minimal Residual Disease and Complete Response in Multiple M... |
Jan 21, 2026 |
| 2026-01065 |
Notice |
Issuance of Priority Review Voucher; Rare Pediatric Disease ... |
Jan 21, 2026 |
| 2026-00792 |
Notice |
Agency Information Collection Activities; Submission for Off... |
Jan 16, 2026 |
| 2026-00325 |
Notice |
Use of Bayesian Methodology in Clinical Trials of Drug and B... |
Jan 12, 2026 |
| 2026-00026 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 6, 2026 |
| 2025-24268 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 5, 2026 |
| 2025-24269 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 5, 2026 |
| 2025-24267 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 5, 2026 |
| 2025-24270 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Jan 5, 2026 |
| 2024-03024 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03025 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03029 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03032 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03022 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03020 |
Notice |
Ross Lucien: Final Debarment Order |
Feb 14, 2024 |
| 2024-03026 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03030 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03019 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03031 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03034 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03039 |
Notice |
Training Program for Regulatory Project Managers; Informatio... |
Feb 14, 2024 |
| 2024-03028 |
Notice |
Determination of Regulatory Review Period for Purposes of Pa... |
Feb 14, 2024 |
| 2024-03036 |
Notice |
Kalpen D. Patel: Final Debarment Order |
Feb 14, 2024 |
| 2024-02849 |
Notice |
Use of Data Monitoring Committees in Clinical Trials; Draft ... |
Feb 13, 2024 |
| 2024-02741 |
Final Rule |
Biologics License Applications and Master Files |
Feb 12, 2024 |
| 2024-02841 |
Notice |
Fiscal Year 2024 Generic Drug Science and Research Initiativ... |
Feb 12, 2024 |
| 2024-02836 |
Notice |
Advanced Manufacturing Technologies Designation Program; Dra... |
Feb 12, 2024 |
| 2024-02838 |
Notice |
Recommendations for Collecting Representative Samples for Fo... |
Feb 12, 2024 |
| 2024-02706 |
Notice |
Brendon Gagne: Final Debarment Order |
Feb 9, 2024 |
| 2024-02709 |
Notice |
Vaccines and Related Biological Products Advisory Committee;... |
Feb 9, 2024 |
| 2024-02710 |
Notice |
Determination That QMIIZ (Meloxicam) Orally Disintegrating T... |
Feb 9, 2024 |
| 2024-02573 |
Notice |
International Drug Scheduling; Convention on Psychotropic Su... |
Feb 8, 2024 |
| 2024-02576 |
Final Rule |
Sensient Colors, LLC.; Filing of Color Additive Petition |
Feb 8, 2024 |
| 2024-02579 |
Notice |
Agency Information Collection Activities; Announcement of Of... |
Feb 8, 2024 |